CJC-1295 with DAC is a growth hormone-releasing hormone analogue modified with a Drug Affinity Complex, which binds albumin and extends its half-life dramatically compared with the non-DAC form. That property is what makes it a reference compound in research on sustained GH release along the GH/IGF axis. Available in a 5mg size; other sizes can be considered to fit your protocol.
Certified laboratory results accompany each batch — purity ≥99.4%, LC-MS identity verification, endotoxin <0.5 EU/mg.
The dry vial is stable at 2–8 °C away from direct light; reconstituted solution is best used within 3–4 weeks. Delivery across Indonesia using secure packaging.
For in-vitro and laboratory research use only.